Have any questions or comments? Send us a message or email us here. We will get back to you soon.
Contact Us
ACTOnco®Pro 'Dual-Core' genomic profiling deploys Next Generation Sequencing (NGS) technology to analyzes >400 genes in tumor DNA and 13 fusion genes with >350 fusion partners in tumor RNA to assist physicians identify the most suitable therapies.
ACTPreis™ G-U is a targeted, multi-biomarker assay that examines 10 actionable genes by tumor DNA+RNA in cholangiocarcinoma, gastric cancer and bladder cancer
ACTPreis™ GI is a targeted, multi-biomarker assay that examines 10 actionable genes by tumor DNA+RNA in metastatic colorectal cancer and gastrointestinal stromal tumors (GIST).
ACTPreis™ Thorax 'Dual-Core' NGS is a targeted, multi-biomarker assay that examines 13 actionable genes by tumor DNA+RNA in non-small cell lung cancer.
Have any questions or comments? Send us a message or email us here. We will get back to you soon.
Contact Us
